Analyst Ratings for Valeant Pharmaceuticals International Inc. (VRX)

Updated: 2017-07-26

An average rating of Hold has been given to Valeant Pharmaceuticals International Inc. (NYSE:VRX) by analysts covering the stock. A consensus rating of Hold was previously issued for VRX last month.

A buy rating was issued by 3 analysts, 1 gave an overweight rating, 13 gave a hold rating, 1 gave an underweight rating, and 4 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 1. During this time, the number of analysts bearish on the stock has increased by 0.

Investment analysts gave a few price targets for VRX. The most optimistic analyst gave a price target of 35, implying a possible profit of 95.26 percent. The most pessimistic analyst gave a price target of 8, implying potential capital losses of -55.37 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Analysts have revised their earnings estimates upwards for this quarter, by about 0.53 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is 0.54 percent. On the other hand, earnings estimates for the fiscal year have been revised downwards by -0.27 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of -6.2 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 2 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts revised their estimates downwards. During this time, 2 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 2 analysts that revised their FY estimates downwards.

VRX has traded between a high of 32.75 and a low of 8.31 over the past year. The current market price is above the trailing year's low by 115.7 percent, and below the high by 45.27 percent. VRX has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The VRX value stock report compares VRX to some of its peers using value stock charts. The stock has a market capitalization of $7.72 billion. VRX will post this quarters earnings in days, on 0000-00-00.